Biomea Fusion, Inc.(BMEA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BMEA Biomea Fusion, Inc.

Closed 09-22 16:00:00 EDT

1.70

-0.01

-0.58%

盘后1.38

-0.32-18.82%

19:58 EDT

High1.78	Low1.66	Vol2.34M
Open1.71	D1 Closing1.71	Amplitude7.02%
Mkt Cap122.91M	Tradable Cap113.91M	Total Shares72.30M
T/O3.77M	T/O Rate3.49%	Tradable Shares67.01M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BMEA","market":"US","secType":"STK","nameCN":"Biomea Fusion, Inc.","latestPrice":1.7,"timestamp":1790107200000,"preClose":1.71,"halted":0,"volume":2337434,"hourTrading":{"tag":"盘后","latestPrice":1.38,"preClose":1.7,"latestTime":"19:58 EDT","volume":1246444,"amount":1707188.3671,"timestamp":1790121494258,"change":-0.32,"changeRate":-0.188235,"amplitude":0.235294},"delay":0,"changeRate":-0.005847953216374275,"floatShares":67007373,"shares":72299440,"eps":-0.471065,"marketStatus":"Closed","change":-0.01,"latestTime":"09-22 16:00:00 EDT","open":1.71,"high":1.78,"low":1.66,"amount":3767868.810112,"amplitude":0.070175,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.471065,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1790150400000},"marketStatusCode":5,"adr":0,"listingDate":1618545600000,"exchange":"NASDAQ","adjPreClose":1.71,"preHourTrading":{"tag":"盘前","latestPrice":1.74,"preClose":1.71,"latestTime":"09:20 EDT","volume":29834,"amount":51035.717070800005,"timestamp":1790083226332,"change":0.03,"changeRate":0.017544,"amplitude":0.046784},"postHourTrading":{"tag":"盘后","latestPrice":1.38,"preClose":1.7,"latestTime":"19:58 EDT","volume":1246444,"amount":1707188.3671,"timestamp":1790121494258,"change":-0.32,"changeRate":-0.188235,"amplitude":0.235294},"volumeRatio":1.511596,"impliedVol":1.2757,"impliedVolPercentile":0.6653},"requestUrl":"/m/hq/s/BMEA/","defaultTab":"news","newsList":[{"id":"2669122740","title":"Biomea Fusion Updates Timeline for BMF-650 Phase I Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2669122740","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669122740?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:38","pubTimestamp":1790109515,"startTime":"0","endTime":"0","summary":"Biomea Fusion ( ($BMEA) ) has provided an update. On September 22, 2026, Biomea Fusion, Inc. reported an updated timeline for topline results from ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biomea-fusion-updates-timeline-for-bmf-650-phase-i-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biomea-fusion-updates-timeline-for-bmf-650-phase-i-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BMEA","BK4585","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669122737","title":"Biomea Fusion announces offering of common stock and warrants, no amount given","url":"https://stock-news.laohu8.com/highlight/detail?id=2669122737","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669122737?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:16","pubTimestamp":1790108172,"startTime":"0","endTime":"0","summary":"Biomea Fusion (BMEA) announced that it has commenced an underwritten public offering of shares of its common stock and, in lieu of common stock to ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biomea-fusion-announces-offering-of-common-stock-and-warrants-no-amount-given-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biomea-fusion-announces-offering-of-common-stock-and-warrants-no-amount-given-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4539","BK4139","BMEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669122854","title":"Biomea Fusion Launches Underwritten Public Offering of Common Stock, Pre-Funded Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2669122854","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669122854?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:06","pubTimestamp":1790107604,"startTime":"0","endTime":"0","summary":"Biomea Fusion launches underwritten public offering of common stock, pre-funded warrantsBiomea Fusion launched an underwritten public offering of common stock, with pre-funded warrants available in li","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL6Znsrh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","BCDF","BMEA","IE00BN0W2W23.USD","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","IE00BGHQF748.EUR","SG9999014021.USD","SG9999014039.USD","LU2210149790.SGD","SG9999014013.SGD","IE00BQXX3D17.EUR","LU0314104364.USD","BK4139","IE00BN0W2V16.EUR","BK4585","BK4539","IE00B3QW5Z07.USD","IE00BQXX3F31.USD","IE00BQXX3C00.GBP","BK4112","LU2095319765.USD","NDAQ","IE00BKPKM429.USD","BK4588","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669124015","title":"Biomea Fusion Announces Proposed Public Offering of Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2669124015","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669124015?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:05","pubTimestamp":1790107501,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUA20XGZ9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","BK4585","BMEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669124082","title":"Biomea Fusion - Topline Results from Phase I Glp-131 Trial for Bmf-650 Expected in October 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2669124082","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669124082?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:02","pubTimestamp":1790107340,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nFWN45E0OA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4585","BMEA","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664779048","title":"Biomea Fusion to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664779048","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664779048?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:00","pubTimestamp":1788436800,"startTime":"0","endTime":"0","summary":"SAN CARLOS, Calif., Sept.  03, 2026 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or “Company” or “Company management”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announc","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3355833/0/en/biomea-fusion-to-participate-in-upcoming-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4585","BMEA","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663972420","title":"Biomea Fusion Completes Key Phase 2 Trial in Type 1 Diabetes: What Investors Should Watch Next","url":"https://stock-news.laohu8.com/highlight/detail?id=2663972420","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663972420?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:30","pubTimestamp":1787934613,"startTime":"0","endTime":"0","summary":"Biomea Fusion Inc ($BMEA) announced an update on their ongoing clinical study. Biomea Fusion Inc. has completed a mid-stage study of BMF-219 in adu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biomea-fusion-completes-key-phase-2-trial-in-type-1-diabetes-what-investors-should-watch-next?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biomea-fusion-completes-key-phase-2-trial-in-type-1-diabetes-what-investors-should-watch-next?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ISBC","BK4211","BK4139","BK4585","BK4539","BMEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662203426","title":"Biomea Shares Rise After Completing Enrollment in Diabetes Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662203426","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662203426?lang=en_us&edition=fundamental","pubTime":"2026-08-25 02:47","pubTimestamp":1787597276,"startTime":"0","endTime":"0","summary":"Biomea Fusion  shares rose over 14% in Monday trading after the firm said it has completed enrollment in a phase 2 trial of icovamenib in insulin-deficient Type 2 diabetes patients.The clinical-stage firm said topline 26-week primary endpoint data from the COVALENT-211 trial is expected in Q1 of 2027.Biomea also said COVALENT-212 mid-stage trial enrollment is still ongoing, with topline 26-week primary endpoint data anticipated in Q2 of 2027.Price: 1.57, Change: +0.20, Percent Change: +14.60","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BMEA","BK4539","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661271007","title":"Unusually active option classes on open August 24th","url":"https://stock-news.laohu8.com/highlight/detail?id=2661271007","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661271007?lang=en_us&edition=fundamental","pubTime":"2026-08-24 21:40","pubTimestamp":1787578821,"startTime":"0","endTime":"0","summary":"Unusual total active option classes on open include: Biomea Fusion (BMEA), Vale (VALE), 21Vianet (VNET), Tractor Supply (TSCO), Humana (HUM), Pindu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/unusually-active-option-classes-on-open-august-24th-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/unusually-active-option-classes-on-open-august-24th-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4516","LU0211331839.USD","LU0075056555.USD","BMEA","BK4607","LU0788109048.HKD","BK4200","LU1046422090.SGD","LU0266013472.USD","BK4531","BK4566","SG9999014013.SGD","BK4585","VALE","LU0070302665.USD","LU0572108347.SGD","VALG","LU0823046494.USD","BK4154","LU0106259046.USD","TSCO","LU0072463663.USD","IHF","SG9999014005.SGD","LU0254981946.USD","IE00B3M56506.USD","LU0238689110.USD","LU0256859116.SGD","LU0348723411.USD","LU0265267285.USD","HUM","BK4533","LU0531970944.HKD","LU0256863811.USD","LU1974910355.USD","LU0265266980.USD","LU1941712264.USD","VNET","LU1941712348.USD","LU0320765489.SGD","LU0612318385.USD","LU1917777945.USD","LU0788109121.HKD","BK4548","FXH","SLX","LU0390134368.USD","IE00B1B80R65.USD","LU0417517546.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661275857","title":"Biomea Fusion completes enrollment in COVALENT-211 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2661275857","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661275857?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:15","pubTimestamp":1787570122,"startTime":"0","endTime":"0","summary":"Biomea Fusion (BMEA) announced the completion of enrollment in COVALENT-211, a randomized, double-blinded, placebo-controlled Phase II clinical tri...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biomea-fusion-completes-enrollment-in-covalent-211-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biomea-fusion-completes-enrollment-in-covalent-211-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","BMEA","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661733312","title":"Biomea Fusion, - Topline 26-Week Primary Endpoint Data from Covalent-211 Expected in Q1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2661733312","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661733312?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:00","pubTimestamp":1787569201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUA4VMQST:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4585","BK4539","BMEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661361273","title":"Biomea Fusion Announces Completion of Enrollment in Covalent-211 Phase Ii Trial of Icovamenib in Insulin-Deficient Type 2 Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2661361273","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661361273?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:00","pubTimestamp":1787569201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUA4VMQST:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4539","BMEA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660359488","title":"Biomea Fusion doses first patient in OPAL study","url":"https://stock-news.laohu8.com/highlight/detail?id=2660359488","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660359488?lang=en_us&edition=fundamental","pubTime":"2026-08-17 15:38","pubTimestamp":1786952287,"startTime":"0","endTime":"0","summary":"Biomea Fusion (BMEA) announced that the first participant has been dosed in a new arm of the ongoing platform research study, Investigating and Opt...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biomea-fusion-doses-first-patient-in-opal-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biomea-fusion-doses-first-patient-in-opal-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BMEA","BK4139","BK4138","OPAL","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659168244","title":"Analysts Offer Insights on Healthcare Companies: Connect Biopharma Holdings (CNTB) and Biomea Fusion (BMEA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659168244","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659168244?lang=en_us&edition=fundamental","pubTime":"2026-08-13 22:10","pubTimestamp":1786630208,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Connect Biopharma Holdings (CNTB) and Biomea Fusion ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-connect-biopharma-holdings-cntb-and-biomea-fusion-bmea-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-connect-biopharma-holdings-cntb-and-biomea-fusion-bmea-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BMEA","BK4539","LABU","LU0128526141.USD","XLV","BK4581","HCSG","BK4139","CNTB","BK4588","BK4585","XBI","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659156597","title":"Biomea Fusion Doses First Patient in OPAL Trial of Icovamenib Plus Semaglutide for Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2659156597","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659156597?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:03","pubTimestamp":1786619009,"startTime":"0","endTime":"0","summary":"Biomea Fusion doses first patient in OPAL trial of icovamenib plus semaglutide for obesityBiomea Fusion dosed the first participant in a new OPAL trial arm testing icovamenib with low-dose semaglutide","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDLVnzpX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BCDF","BK4139","SG9999014021.USD","LU0314104364.USD","SG9999014005.SGD","BK4539","BMEA","IE00BN0W2W23.USD","LU2210149790.SGD","BK4588","IE00B3QW5Z07.USD","NDAQ","SG9999014013.SGD","SG9999014039.USD","BK4585","IE00BGHQF748.EUR","IE00BKPKM429.USD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","LU2095319765.USD","IE00B64PRP62.GBP","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659155084","title":"Biomea Fusion Announces First Patient Dosed in Opal Study Evaluating Icovamenib in Combination with Semaglutide in Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2659155084","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659155084?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:00","pubTimestamp":1786618802,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUA77KTHB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4539","BMEA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658994062","title":"Citi adds ‘upside 90-day catalyst watch’ on Biomea into GLP-1 data","url":"https://stock-news.laohu8.com/highlight/detail?id=2658994062","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658994062?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:00","pubTimestamp":1786446032,"startTime":"0","endTime":"0","summary":"Citi analyst Yigal Nochomovitz added an “upside 90-day catalyst watch” on Biomea Fusion (BMEA) while keeping a Buy rating on the shares with a $7 p...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/citi-adds-upside-90-day-catalyst-watch-on-biomea-into-glp-1-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/citi-adds-upside-90-day-catalyst-watch-on-biomea-into-glp-1-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","JDOC","BK4590","BK4585","GLP","BK4144","BK4539","BMEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657965016","title":"Vaxart Q2 Revenue Falls on Lower Government Contract Income","url":"https://stock-news.laohu8.com/highlight/detail?id=2657965016","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657965016?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:19","pubTimestamp":1786047545,"startTime":"0","endTime":"0","summary":"Vaxart Q2 revenue falls on lower government contract incomeOverviewUS oral vaccine developer's Q2 revenue fell yr/yr, mainly on lower government contract revenueNet loss for Q2 narrowed from prior yea","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4431FN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","BK4548","BMEA","BK4568","VXRT","BK4585","BK4535","BK4539","BNTX","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657165235","title":"Biomea Fusion price target lowered to $7 from $9 at Citizens","url":"https://stock-news.laohu8.com/highlight/detail?id=2657165235","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657165235?lang=en_us&edition=fundamental","pubTime":"2026-08-07 03:25","pubTimestamp":1786044343,"startTime":"0","endTime":"0","summary":"Citizens lowered the firm’s price target on Biomea Fusion (BMEA) to $7 from $9 and keeps an Outperform rating on the shares. The firm noted that da...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biomea-fusion-price-target-lowered-to-7-from-9-at-citizens-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biomea-fusion-price-target-lowered-to-7-from-9-at-citizens-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657663442","title":"Biomea Fusion (BMEA) Gets a Buy from Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2657663442","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657663442?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:57","pubTimestamp":1786021056,"startTime":"0","endTime":"0","summary":"In a report released today, Matthew Biegler from Oppenheimer reiterated a Buy rating on Biomea Fusion, with a price target of $9.00. According to T...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/biomea-fusion-bmea-gets-a-buy-from-oppenheimer-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/biomea-fusion-bmea-gets-a-buy-from-oppenheimer-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMEA","OPY","BK4139","BK4585","BK4127","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biomeafusion.com","stockEarnings":[{"period":"1week","weight":-0.0393},{"period":"1month","weight":0.2482},{"period":"3month","weight":0.3902},{"period":"6month","weight":0.4016},{"period":"1year","weight":-0.1231},{"period":"ytd","weight":0.379}],"compareEarnings":[{"period":"1week","weight":0.0166},{"period":"1month","weight":0.0102},{"period":"3month","weight":0.0544},{"period":"6month","weight":0.1776},{"period":"1year","weight":0.1654},{"period":"ytd","weight":0.1343}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Biomea Fusion, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin for treating patients with liquid and solid tumors and type 2 diabetes. Biomea Fusion, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.06322},{"month":2,"riseRate":0.4,"avgChangeRate":0.025302},{"month":3,"riseRate":0.4,"avgChangeRate":0.163799},{"month":4,"riseRate":0,"avgChangeRate":-0.156763},{"month":5,"riseRate":0.666667,"avgChangeRate":0.113922},{"month":6,"riseRate":0.5,"avgChangeRate":0.078877},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.050106},{"month":8,"riseRate":0.833333,"avgChangeRate":0.137883},{"month":9,"riseRate":0.5,"avgChangeRate":-0.007366},{"month":10,"riseRate":0.2,"avgChangeRate":-0.126858},{"month":11,"riseRate":0.4,"avgChangeRate":-0.034764},{"month":12,"riseRate":0.4,"avgChangeRate":-0.114655}],"exchange":"NASDAQ","name":"Biomea Fusion, Inc.","nameEN":"Biomea Fusion, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Biomea Fusion, Inc.(BMEA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Biomea Fusion, Inc.(BMEA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Biomea Fusion, Inc.,BMEA,Biomea Fusion, Inc.股票,Biomea Fusion, Inc.股票老虎,Biomea Fusion, Inc.股票老虎国际,Biomea Fusion, Inc.行情,Biomea Fusion, Inc.股票行情,Biomea Fusion, Inc.股价,Biomea Fusion, Inc.股市,Biomea Fusion, Inc.股票价格,Biomea Fusion, Inc.股票交易,Biomea Fusion, Inc.股票购买,Biomea Fusion, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Biomea Fusion, Inc.(BMEA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Biomea Fusion, Inc.(BMEA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}